The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer

Subjects

Subjects :

neoangiogenesis
follicular thyroid cancer
sunitinib
levothyroxine
radioactive iodine
AKT/PI3K pathways
tyrosin-kinase inhibitor
PDGFR-α
RET/PTC
VEGF
Thyroid cancer
refractory DTC
VEGFR
MAPK kinase
TSH suppressive
macrocytosis
metastasis
papillary thyroid cancer
hypothyroidism
RET
AKT/PI3K pathways, follicular thyroid cancer, hypothyroidism, levothyroxine, macrocytosis, MAPK kinase, metastasis, neoangiogenesis, papillary thyroid cancer, PDGFR-ß, PDGFR-α, radioactive iodine, refractory DTC, RET, RET/PTC, sunitinib, Thyroid cancer, TSH suppressive, tyrosin-kinase inhibitor, VEGF, VEGFR
PDGFR-ß

Details

Language :

English

Database :

OpenAIRE

Accession number :

edsair.doi.dedup.....3c4f9efab7c6f7f858e112905ec8e21f